EU Approves €385M IMS-Cegedim Deal Pending Fixes
The European Commission on Friday cleared market researcher IMS Health's €385 million ($470.1 million) acquisition of parts of French rival Cegedim's business, conditioned on certain divestitures and agreements, concluding the revised...To view the full article, register now.
Already a subscriber? Click here to view full article